“Long-Term Improvements Observed in Tralokinumab-Treated Patients With Moderate-to-Severe Atopic Dermatitis: An ECZTEND Interim Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s59, https://doi.org/10.25251/skin.5.supp.59.